Avalo Therapeutics Announces 1-for-240 Reverse Stock Split
WAYNE, Pa. and ROCKVILLE, Md., Dec. 27, 2023 (GLOBE NEWSWIRE) — Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced a 1-for-240 […]
WAYNE, Pa. and ROCKVILLE, Md., Dec. 27, 2023 (GLOBE NEWSWIRE) — Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced a 1-for-240 […]
CAMBRIDGE, Mass., Dec. 27, 2023 (GLOBE NEWSWIRE) — Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically […]
VANCOUVER, British Columbia, Dec. 27, 2023 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) (the “Company” or […]
BRISBANE, Calif., Dec. 27, 2023 (GLOBE NEWSWIRE) — Annexon, Inc. (Nasdaq: ANNX) a clinical-stage biopharmaceutical company developing a new class […]
DUBAI, United Arab Emirates, Dec. 27, 2023 (GLOBE NEWSWIRE) — Swvl Holdings Corp (“Swvl” or the “Company”) (Nasdaq: SWVL), a […]
BOCA RATON, Fla., Dec. 27, 2023 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the […]
Opthea to receive remaining US$35m funding under the Development Funding Agreement (DFA) with Carlyle and its life science franchise Abingworth, […]
GUANGZHOU, China, Dec. 27, 2023 (GLOBE NEWSWIRE) — Puyi Inc. (NASDAQ: PUYI) (“Puyi”), a leading third-party wealth management services provider […]
HOLMDEL, N.J. and MADRID, Spain, Dec. 27, 2023 (GLOBE NEWSWIRE) — BIO-key®International, Inc. (NASDAQ: BKYI), an innovative provider of workforce […]
GUANGZHOU, China, Dec. 27, 2023 (GLOBE NEWSWIRE) — FANHUA Inc. (“FANHUA” or “the Company”) (Nasdaq: FANH), a leading independent financial […]